Summary
Three hundred and sixty five couples with 3 or more spontaneous primary abortions were immunologically evaluated after their clinical workup and revealed no aetiology for their recurrent losses. One hundred and seventy three women in this group qualified for paternal leucocyte immunisation. The remainder received no therapy. Reproductive performance following workup and therapy revealed: 100/121 women immunised with paternal leucocytes established a pregnancy and delivered live infants; 21/121 aborted an additional time following immunisation. Subsequently these women were immunised twice with HLA incompatible leucocytes from the same non-paternal female donor and were retested immunologically. Of these 15/21 have delivered live infants. Six women aborted their pregnancy following non-paternal leucocyte immunisation. Thirteen/51 women qualifying for and awaiting treatment established a pregnancy and delivered, the remainder aborted an additional time. Twelve couples established a second pregnancy one year or longer following leucocyte immunisation. Six of the women not reimmunised aborted this pregnancy, the six reimmunised with paternal leucocytes delivered a second live infant. We conclude: 1) The incidence of a live born infants in couples with 3 or more spontaneous abortions is very low; 2) Paternal leucocyte immunisation results in an 83% live birth incidence; 3) Reproductive outcome following paternal leucocyte therapy correlates with in vitro immune response profiles; 4) Non-paternal leucocyte therapy is highly successful in women previously failing paternal leucocyte therapy and in women who experienced severe intrauterine growth retardation following paternal leucocyte immunisation. We suggest that this subgroup of 21 couples aborting an additional time post paternal leucocyte therapy may share the same trophoblast lymphocyte crossreactive (TLX) antigens. As a result the female IS incapable of initiating the pregnancy associated responses necessary for the immunoprotection and growth stimulation of the trophoblast. Leucocytes from the non-paternal donor initiated measurable immune responses in most and this response was associated with improved reproductive outcome. The immunological significance of these findings is discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Chaouat G, Kolb JP, Wegmann TG. The murine placenta as an immunological barrier between the mother and the fetus. lmmunol Rev 1983; 75: 31–60.
Chaouat G, Kiger N, Wegmann TG: Vaccination against spontaneous abortion in mice. J Reprod Immunol 1983; 5: 389–392.
Beer AE, Quebbeman JF, Hamazaki Y, Semprini AE: Pregnancy outcome in human couples with recurrent spontaneous abortions: The role(s) of HLA antigen sharing, ABO blood group antigen profiles, female serum MLR blocking factors, antisperm antibodies and immunotherapy. In: lmmunoregulation and Fetal Survival. Eds. Gill TJ, Wegmann TG. New York and Oxford: Oxford University Press, 1987; pp 286.
Menge AC, Beer AE. The significance of human leucocyte antigen profiles in human infertility, recurrent abortion, and pregnancy disorders. Fertil Steril 1985; 43: 693–695.
Beer AE, Quebbeman JF, Ayers JWT, Haines RF. Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans. Am J Obstet Gynecol 1981; 141: 987–999.
Beer AE. Immunopathologic factors contributing to recurrent spontaneous abortion in humans (editorial). Am J Reprod Immunol 1983; 4: 182–184.
Beer AE: How did your mother not reject you? Ann Immunol 1984; 135D: 315–318.
Beer AE, Semprini AE, Zhu X, Quebbeman JF. Pregnancy outcome in human couples with recurrent spontaneous abortions: 1) HLA antigen profiles; 2) HLA antigen sharing; 3) Female serum MLR blocking factors and 4) Paternal leukocyte immunization. Exp Clin lmmunogenet 1985; 2: 137.
Edmonds DK, Lindsay KS, Miller JF, Williamson E, Wood PJ. Early embryonic mortality in women. Fertil Steril 1982; 38: 447–453.
Warburton D, Fraser F. Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. Hum Genet 1964; 16: 1.
Graves WL. Psychological aspects of spontaneous abortion. In: Spontaneous and Recurrent Abortion. Eds. MJ Bennett, DK Edmonds. Oxford: Blackwell Scientific Publications, 1987; pp 214.
Malpas P. A study of abortion sequences. J Obstet Gynaecol Br Empire. 1938; 45: 932–949.
Eastman NJ. Habitual abortion. In: Progress in Gynecology. (Eds.) JV Meigs, SH Sturgis. New York: Grune and Stratton, pp 262.
James WH. Control data for evaluating the efficacy of psychotherapy in habitual spontaneous abortion. Br J Psychiatry 1963; 109: 81.
James WH. Notes toward an epidemiology of spontaneous abortion. Am J Hum Genet 1963; 15: 223.
MacNaughton MC. The probability of recurrent abortion. J Obstet Gynaecol Br Commonw 1964; 71: 784.
Elias S, Simpson JL. Evaluation and clinical management of patients at apparent increased risk for spontaneous abortions. In: Human Embryonic and Human Death. Eds. I Porter, EB Hook. New York: Academic Press 1980; pp 331.
Warburton D, Fraser FC. On the probability that a woman who has had a spontaneous abortion will abort in subsequent pregnancies. J Obstet Gynaecol Br Commonw 1961; 68: 784–788.
Stray-Pederson B, Stray-Pederson S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984; 148: 140–146.
Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A,-B,-C and-D antigens. Am J Clin Pathol 1978; 69: 103–120.
Chaouat G, Voisin GA. Regulatory T cell subpopulations in pregnancy. I. Evidence for suppressive activity of the early phase of MLR. J Immunol 1979; 122: 1383–1388.
Mcintyre JA, Faulk WP. Allotypic trophoblast-lymphocyte cross-reactive (TLX) cell surface antigens. Human Immunol 1982; 4: 27–35.
Nicholas NS, Panayi GS, Nouri AM. Human pregnancy serum inhibits interleukin- 2 production. Clin Exp Immunol 1984; 58: 587–595.
Domingo-Garcia CG, Domenech N, Aparicio P, Palomino P. Human pregnancy serum inhibits proliferation of T8-depleted cells and their interleukin-2 synthesis in mixed lymphocyte cultures. J Reprod Immunol 1985; 8: 97–110.
Suciu-Foca N, Reed E, Rohowsky C, Kung P, King DW. Anti-idiotypic antibodies to anti-HLA receptors induced by pregnancy. Proc Natl Acad Sci USA 1983; 80: 830–834.
Figueredo MA, Palomino P and Ortiz F. Lymphocyte response to phytohemagglutinin in the presence of serum from pregnant women: correlation with serum levels of alphafetoprotein. Clin Exp Immunol 1979; 37: 140–144.
Kim SJ, Christiansen FT, Gosar I, Silver DM, Pollack MS, Dupont B. Frequency of alloantibodies reacting with PHA activated T lymphocytes, unexplainable by known HLA activities. Human Immunol 1980; 4: 347–355.
Konoeda Y, Terasaki PI, Wakisaka A, Park MS, Mickey MR. Public determinants of HLA indicated by pregnancy antibodies. Transplantation 1986; 41: 253–259.
Jerne NK. Towards a network theory of the immune system. Ann Immunol 1974; 125c: 373–379.
Reed E, Bonagura V, Kung P, King DW, Suciu-Foca N. Anti-idiotypic antibodies to HLA-DR4 and DR2. J Immunol 1983; 131: 2890–2894.
Suciu-Foca N, Rohowsky C, Kung P, King DW. Idiotype-like determinants on human T lymphocytes alloactivated in mixed lymphocyte culture. J Exp Med 1982; 156: 283–288.
Klatzmann D, Gluckman JC, Foucault C. Modification of mixed lymphocyte reactivity after blood transfusions in man. Transplantation Proceedings 1983; 15: 1016–1018.
Clark DR. Local suppressor cells and the success or failure of the “foetal allograft”. Ann Immunol 1984; 135D: 21–24.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 The Royal College of Obstetricians and Gynaecologists
About this chapter
Cite this chapter
Beer, A.E. (1988). Pregnancy outcome in couples with recurrent abortions following immunological evaluation and therapy. In: Sharp, F., Beard, R.W. (eds) Early Pregnancy Loss. Springer, London. https://doi.org/10.1007/978-1-4471-1658-5_46
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1658-5_46
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1660-8
Online ISBN: 978-1-4471-1658-5
eBook Packages: Springer Book Archive